Relative Neurotropism of a Recombinant Rhabdovirus Expressing a Green Fluorescent Envelope Glycoprotein

ABSTRACT A new recombinant vesicular stomatitis virus (rVSV) that expresses green fluorescent protein (GFP) on the cytoplasmic domain of the VSV glycoprotein (G protein) was used in the mouse as a model for studying brain infections by a member of the Mononegavirales order that can cause permanent changes in behavior. After nasal administration, virus moved down the olfactory nerve, first to periglomerular cells, then past the mitral cell layer to granule cells, and finally to the subventricular zone. Eight days postinoculation, rVSV was eliminated from the olfactory bulb. Little sign of infection could be found outside the olfactory system, suggesting that anterograde or retrograde axonal transport of rVSV was an unlikely mechanism for movement of rVSV out of the bulb. When administered intracerebrally by microinjection, rVSV spread rapidly within the brain, with strong infection at the site of injection and at some specific periventricular regions of the brain, including the dorsal raphe, locus coeruleus, and midline thalamus; the ventricular system may play a key role in rapid rVSV dispersion within the brain. Thus, the lack of VSV movement out of the olfactory system was not due to the absence of potential for infections in other brain regions. In cultures of both mouse and human central nervous system (CNS) cells, rVSV inoculations resulted in productive infection, expression of the G-GFP fusion protein in the dendritic and somatic plasma membrane, and death of all neurons and glia, as detected by ethidium homodimer nuclear staining. Although considered a neurotropic virus, rVSV also infected heart, skin, and kidney cells in dispersed cultures. rVSV showed a preference for immature neurons in vitro, as shown by enhanced viral infection in developing hippocampal cultures and in the outer granule cell layer in slices of developing cerebellum. Together, these data suggest a relative affinity of rVSV for some neuronal types in the CNS, adding to our understanding of the long-lasting changes in rodent behavior found after transient VSV infection.

[1]  Y. Kawaoka,et al.  Vaccination with a Recombinant Vesicular Stomatitis Virus Expressing an Influenza Virus Hemagglutinin Provides Complete Protection from Influenza Virus Challenge , 1998, Journal of Virology.

[2]  R. Tesh,et al.  A human case of encephalitis associated with vesicular stomatitis virus (Indiana serotype) infection. , 1988, The American journal of tropical medicine and hygiene.

[3]  I. Pastan,et al.  Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site? , 1983, Cell.

[4]  E. Boritz,et al.  Replication-Competent Rhabdoviruses with Human Immunodeficiency Virus Type 1 Coats and Green Fluorescent Protein: Entry by a pH-Independent Pathway , 1999, Journal of Virology.

[5]  D. Dave,et al.  Isolation of Chandipura virus from the blood in acute encephalopathy syndrome. , 1983, The Indian journal of medical research.

[6]  F. Fonnum,et al.  Persistent changes in behaviour and brain serotonin during ageing in rats subjected to infant nasal virus infection , 1992, Neurobiology of Aging.

[7]  F. Dudek,et al.  Pseudorabies virus expressing enhanced green fluorescent protein: A tool for in vitro electrophysiological analysis of transsynaptically labeled neurons in identified central nervous system circuits. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Kristensson,et al.  SELECTIVE INFECTIONS OF OLFACTORY AND RESPIRATORY EPITHELIUM BY VESICULAR STOMATITIS AND SENDAI VIRUSES , 1987, Neuropathology and applied neurobiology.

[9]  K. Kristensson,et al.  Immunohistochemical and behaviour pharmacological analysis of rats inoculated intranasally with vesicular stomatitis virus , 1993, Journal of Chemical Neuroanatomy.

[10]  J. Rose,et al.  Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. N. van den Pol,et al.  Cytomegalovirus Cell Tropism, Replication, and Gene Transfer in Brain , 1999, The Journal of Neuroscience.

[12]  T. Johnson,et al.  Cytopathic effects in mouse neuroblastoma cells during a non-permissive infection with a mutant of vesicular stomatitis virus. , 1981, The Journal of general virology.

[13]  R. Zinkernagel,et al.  Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice , 1995, Journal of virology.

[14]  L. Enquist,et al.  Two alpha-herpesvirus strains are transported differentially in the rodent visual system. , 1991, Neuron.

[15]  J. Rose,et al.  Vesicular stomatitis virus glycoprotein containing the entire green fluorescent protein on its cytoplasmic domain is incorporated efficiently into virus particles. , 2001, Virology.

[16]  M. D. Dal Canto,et al.  Murine central nervous system infection by a viral temperature-sensitive mutant: a subacute disease leading to demyelination. , 1981, The American journal of pathology.

[17]  K. Kristensson,et al.  Non-Lethal Infection of Aminergic Reticular Core Neurons: Age-Dependent Spread of ts Mutant Vesicular Stomatitis Virus from the Nose , 1988, Journal of neuropathology and experimental neurology.

[18]  J. Kartenbeck,et al.  Polarized distribution of the viral glycoproteins of vesicular stomatitis, fowl plague and Semliki Forest viruses in hippocampal neurons in culture: a light and electron microscopic study , 1993, Brain Research.

[19]  M. Luskin,et al.  Rate and pattern of migration of lineally-related olfactory bulb interneurons generated postnatally in the subventricular zone of the rat. , 1994, Chemical senses.

[20]  A. Roberts,et al.  Redesign and genetic dissection of the rhabdoviruses. , 1999, Advances in virus research.

[21]  A. Sabin,et al.  INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS , 1937, The Journal of experimental medicine.

[22]  A. Sabin,et al.  INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS , 1938, The Journal of Experimental Medicine.

[23]  T. Komatsu,et al.  Interferon-gamma induced type I nitric oxide synthase activity inhibits viral replication in neurons. , 1996, Journal of neuroimmunology.

[24]  H. Koprowski,et al.  Kinetics of virus spread and changes in levels of several cytokine mRNAs in the brain after intranasal infection of rats with Borna disease virus , 1992, Journal of virology.

[25]  C. Aoki,et al.  Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice , 1993, Journal of virology.

[26]  L. Enquist,et al.  Two α-herpesvirus strains are transported differentially in the rodent visual system , 1991, Neuron.

[27]  F. Fonnum,et al.  Behavioural deficits and serotonin depletion in adult rats after transient infant nasal viral infection , 1990, Neuroscience.

[28]  M. Whitt,et al.  A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. , 1991, BioTechniques.

[29]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[30]  Nahum Sonenberg,et al.  Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus , 2000, Nature Medicine.

[31]  T. Komatsu,et al.  Viral Replication in Olfactory Receptor Neurons and Entry into the Olfactory Bulb and Brain a , 1998, Annals of the New York Academy of Sciences.

[32]  L. Enquist,et al.  Different Patterns of Neuronal Infection after Intracerebral Injection of Two Strains of Pseudorabies Virus , 1998, Journal of Virology.

[33]  M. Whitt,et al.  Recombinant vesicular stomatitis viruses from DNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Barber,et al.  Vesicular Stomatitis Virus (VSV) Therapy of Tumors , 2000, IUBMB life.

[35]  C. Aoki,et al.  The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. , 1995, Virology.

[36]  R. Price,et al.  Interferon protects neurons in culture infected with vesicular stomatitis and herpes simplex viruses , 1982, Journal of the Neurological Sciences.

[37]  L. Astic,et al.  Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation , 1991, Virology.

[38]  B L Trus,et al.  Mass and molecular composition of vesicular stomatitis virus: a scanning transmission electron microscopy analysis , 1985, Journal of virology.

[39]  P. Strick,et al.  Direction of transneuronal transport of herpes simplex virus 1 in the primate motor system is strain-dependent. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Komatsu,et al.  Interferon-γ induced type I nitric oxide synthase activity inhibits viral replication in neurons , 1996, Journal of Neuroimmunology.

[41]  K. Simons,et al.  Polarized sorting of viral glycoproteins to the axon and dendrites of hippocampal neurons in culture , 1990, Cell.

[42]  C. Aoki,et al.  Distribution of vesicular stomatitis virus proteins in the brain of BALB/c mice following intranasal inoculation: an immunohistochemical analysis , 1994, Brain Research.

[43]  J. Rose,et al.  Construction of a Novel Virus That Targets HIV-1-Infected Cells and Controls HIV-1 Infection , 1997, Cell.

[44]  C. Lois,et al.  Long-distance neuronal migration in the adult mammalian brain. , 1994, Science.

[45]  Gordon M. Shepherd,et al.  The Olfactory Bulb , 1988 .

[46]  G. Shepherd The Synaptic Organization of the Brain , 1979 .